Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
|
Lancet Oncol
|
2009
|
25.96
|
2
|
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
|
Acta Neuropathol
|
2011
|
3.66
|
3
|
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading.
|
Brain Pathol
|
2014
|
3.21
|
4
|
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
|
Clin Cancer Res
|
2010
|
3.13
|
5
|
Germline mutation of INI1/SMARCB1 in familial schwannomatosis.
|
Am J Hum Genet
|
2007
|
2.53
|
6
|
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.
|
Immunology
|
2013
|
2.14
|
7
|
Diffuse glioma growth: a guerilla war.
|
Acta Neuropathol
|
2007
|
2.11
|
8
|
MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas.
|
Lab Invest
|
2007
|
2.06
|
9
|
In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma.
|
Cancer Cell
|
2010
|
1.94
|
10
|
Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option.
|
Clin Cancer Res
|
2004
|
1.87
|
11
|
Receptor conversion in distant breast cancer metastases.
|
Breast Cancer Res
|
2010
|
1.85
|
12
|
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
|
Lancet Neurol
|
2003
|
1.84
|
13
|
Prognostic significance and mechanism of Treg infiltration in human brain tumors.
|
J Neuroimmunol
|
2010
|
1.70
|
14
|
Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.
|
Acta Neuropathol
|
2010
|
1.65
|
15
|
CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.
|
Int J Cancer
|
2007
|
1.64
|
16
|
Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.
|
Cancer Res
|
2002
|
1.47
|
17
|
RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations.
|
Acta Neuropathol
|
2007
|
1.43
|
18
|
A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.
|
Clin Cancer Res
|
2011
|
1.40
|
19
|
Molecular diagnostics of gliomas: state of the art.
|
Acta Neuropathol
|
2010
|
1.40
|
20
|
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
|
Clin Infect Dis
|
2005
|
1.36
|
21
|
Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra.
|
NMR Biomed
|
2006
|
1.35
|
22
|
Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization.
|
Mol Cancer Ther
|
2008
|
1.31
|
23
|
Aminopeptidase A is a functional target in angiogenic blood vessels.
|
Cancer Cell
|
2004
|
1.28
|
24
|
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
|
Acta Neuropathol
|
2012
|
1.22
|
25
|
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases.
|
Cancer
|
2012
|
1.18
|
26
|
Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics.
|
Brain Pathol
|
2009
|
1.16
|
27
|
Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.
|
J Clin Microbiol
|
2003
|
1.15
|
28
|
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors.
|
Neuro Oncol
|
2008
|
1.15
|
29
|
Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
|
Int J Cancer
|
2008
|
1.14
|
30
|
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
|
Acta Neuropathol
|
2015
|
1.13
|
31
|
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
|
Neuro Oncol
|
2009
|
1.13
|
32
|
Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.
|
Acta Neuropathol
|
2010
|
1.11
|
33
|
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.
|
Acta Neuropathol
|
2015
|
1.11
|
34
|
Primary intracranial germ-cell tumors in adults: a practical review.
|
J Neurooncol
|
2013
|
1.10
|
35
|
Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.
|
J Clin Oncol
|
2012
|
1.10
|
36
|
Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.
|
J Mol Diagn
|
2006
|
1.09
|
37
|
Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model.
|
Brain Pathol
|
2010
|
1.09
|
38
|
Immunotherapy of diffuse gliomas: biological background, current status and future developments.
|
Brain Pathol
|
2009
|
1.07
|
39
|
Collision sellar lesions: experience with eight cases and review of the literature.
|
Pituitary
|
2009
|
1.05
|
40
|
Phenotypic and genotypic characterization of orthotopic human glioma models and its relevance for the study of anti-glioma therapy.
|
Brain Pathol
|
2008
|
1.04
|
41
|
Effects of dual targeting of tumor cells and stroma in human glioblastoma xenografts with a tyrosine kinase inhibitor against c-MET and VEGFR2.
|
PLoS One
|
2013
|
1.02
|
42
|
Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma.
|
Cancer Res
|
2003
|
1.02
|
43
|
Histological effects of fibrin glue on nervous tissue: a safety study in rats.
|
Surg Neurol
|
2002
|
1.01
|
44
|
Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis.
|
J Comp Neurol
|
2005
|
1.01
|
45
|
Severe tacrolimus leukoencephalopathy after liver transplantation.
|
AJNR Am J Neuroradiol
|
2003
|
1.00
|
46
|
Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution.
|
Mod Pathol
|
2013
|
0.98
|
47
|
In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma.
|
PLoS One
|
2013
|
0.98
|
48
|
Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase.
|
Histopathology
|
2011
|
0.97
|
49
|
MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.
|
Clin Cancer Res
|
2013
|
0.97
|
50
|
Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database.
|
J Neurosurg
|
2006
|
0.96
|
51
|
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.
|
Oncotarget
|
2014
|
0.96
|
52
|
Subventricular spread of diffuse intrinsic pontine glioma.
|
Acta Neuropathol
|
2014
|
0.95
|
53
|
Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.
|
FASEB J
|
2012
|
0.95
|
54
|
Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques.
|
Neurobiol Aging
|
2002
|
0.94
|
55
|
Comparative genomic hybridization: practical guidelines.
|
Diagn Mol Pathol
|
2002
|
0.94
|
56
|
Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI.
|
Int J Cancer
|
2003
|
0.93
|
57
|
Protein tyrosine phosphatases in glioma biology.
|
Acta Neuropathol
|
2009
|
0.92
|
58
|
Human pontine glioma cells can induce murine tumors.
|
Acta Neuropathol
|
2014
|
0.92
|
59
|
MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
|
J Pathol
|
2010
|
0.92
|
60
|
Molecular pathogenesis of oligodendroglial tumors.
|
J Neurooncol
|
2004
|
0.91
|
61
|
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG.
|
Acta Neuropathol Commun
|
2013
|
0.91
|
62
|
Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models.
|
J Pathol
|
2011
|
0.90
|
63
|
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
|
Acta Neuropathol
|
2015
|
0.90
|
64
|
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
|
Acta Neuropathol Commun
|
2014
|
0.90
|
65
|
Accurate classification of childhood brain tumours by in vivo ¹H MRS - a multi-centre study.
|
Eur J Cancer
|
2012
|
0.89
|
66
|
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.
|
Genome Biol
|
2014
|
0.89
|
67
|
A pilot study on slit lamp-adapted optical coherence tomography imaging of trabeculectomy filtering blebs.
|
Graefes Arch Clin Exp Ophthalmol
|
2006
|
0.88
|
68
|
Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH.
|
J Pathol
|
2002
|
0.87
|
69
|
Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.
|
Pathol Oncol Res
|
2014
|
0.87
|
70
|
Expression pattern of apoptosis-related markers in Huntington's disease.
|
Acta Neuropathol
|
2005
|
0.86
|
71
|
Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I.
|
Am J Med
|
2013
|
0.85
|
72
|
Chromosomal imbalances in primary oligodendroglial tumors and their recurrences: clues about malignant progression detected using comparative genomic hybridization.
|
J Neurosurg
|
2002
|
0.85
|
73
|
Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expression.
|
Int J Cancer
|
2006
|
0.85
|
74
|
Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting.
|
Neuro Oncol
|
2013
|
0.85
|
75
|
Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains.
|
Brain Pathol
|
2002
|
0.84
|
76
|
Three-dimensional (3D) reconstruction and quantitative analysis of the microvasculature in medulloblastoma and ependymoma subtypes.
|
Angiogenesis
|
2006
|
0.83
|
77
|
Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
|
J Neuropathol Exp Neurol
|
2015
|
0.83
|
78
|
A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Sträussler-Scheinker disease phenotype: comparison with similar cases from the literature.
|
Acta Neuropathol
|
2010
|
0.83
|
79
|
Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
|
Melanoma Res
|
2015
|
0.82
|
80
|
Cyclin D1 genotype and expression in sporadic hemangioblastomas.
|
J Neurooncol
|
2005
|
0.82
|
81
|
The nature and timing of specific copy number changes in the course of molecular progression in diffuse gliomas: further elucidation of their genetic "life story".
|
Brain Pathol
|
2010
|
0.82
|
82
|
3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
|
J Nucl Med
|
2012
|
0.82
|
83
|
Liquid biopsies in patients with diffuse glioma.
|
Acta Neuropathol
|
2015
|
0.82
|
84
|
Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein.
|
Acta Neuropathol
|
2015
|
0.82
|
85
|
Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.
|
Neuro Oncol
|
2013
|
0.81
|
86
|
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
|
Cancer
|
2011
|
0.81
|
87
|
Correlation between contrast enhancement on intraoperative magnetic resonance imaging and histopathology in glioblastoma.
|
Surg Neurol Int
|
2012
|
0.81
|
88
|
Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
|
J Neurosurg
|
2002
|
0.81
|
89
|
White Matter Lesions Are Not Related to β-Amyloid Deposition in an Autopsy-Based Study.
|
Curr Gerontol Geriatr Res
|
2011
|
0.81
|
90
|
Unique Presentation of Corneal Opacity in Peters Plus Syndrome: An Unusual Form of Peters Anomaly Showing Tissue Repair in Serial Analysis.
|
Cornea
|
2016
|
0.80
|
91
|
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases.
|
BMC Cancer
|
2014
|
0.80
|
92
|
Gliomatosis cerebri: quantitative proof of vessel recruitment by cooptation instead of angiogenesis.
|
J Neurosurg
|
2005
|
0.80
|
93
|
SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
|
Am J Surg Pathol
|
2014
|
0.80
|
94
|
Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171.
|
Brain Pathol
|
2014
|
0.79
|
95
|
Cerebral amyloid angiopathy with severe secondary vascular pathology: a histopathological study.
|
Dement Geriatr Cogn Disord
|
2005
|
0.79
|
96
|
Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
|
Acta Neuropathol
|
2014
|
0.79
|
97
|
Molecular diagnostics as a tool to personalize treatment in adult glioma patients.
|
Technol Cancer Res Treat
|
2006
|
0.79
|
98
|
Radiotherapy for partially resected spinal ependymomas: a retrospective study of 60 cases.
|
Oncol Rep
|
2003
|
0.79
|
99
|
Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.
|
Brain Pathol
|
2015
|
0.79
|
100
|
Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.
|
Neurosurgery
|
2016
|
0.78
|
101
|
Re: multiplex ligation dependent probe amplification for the detection of 1p and 19q loss in oligodendroglial tumors.
|
Brain Pathol
|
2005
|
0.78
|
102
|
Selective cancer-germline gene expression in pediatric brain tumors.
|
J Neurooncol
|
2008
|
0.78
|
103
|
Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra.
|
MAGMA
|
2011
|
0.77
|
104
|
Incremental Gaussian Discriminant Analysis based on Graybill and Deal weighted combination of estimators for brain tumour diagnosis.
|
J Biomed Inform
|
2011
|
0.76
|
105
|
Molecular diagnostics of brain tumors.
|
Acta Neuropathol
|
2010
|
0.76
|
106
|
Multiplex blood reporters for simultaneous monitoring of cellular processes.
|
Anal Chem
|
2013
|
0.75
|
107
|
[Neuroschistosomiasis; an unexpected finding in a Dutch woman].
|
Ned Tijdschr Geneeskd
|
2009
|
0.75
|
108
|
Fatal consequences of an ear infection.
|
Lancet
|
2009
|
0.75
|
109
|
Towards an integrated morphological and molecular WHO diagnosis of central nervous system tumors: a paradigm shift.
|
Curr Opin Neurol
|
2015
|
0.75
|
110
|
[Constitutional mismatch repair deficiency syndrome].
|
Ned Tijdschr Geneeskd
|
2015
|
0.75
|
111
|
Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains.
|
J Alzheimers Dis
|
2004
|
0.75
|
112
|
Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma.
|
Acta Neurol Belg
|
2009
|
0.75
|
113
|
Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma.
|
Acta Oncol
|
2010
|
0.75
|
114
|
A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern.
|
Acta Neuropathol
|
2015
|
0.75
|
115
|
Occurrence of ocular melanoma thirteen years after skin melanoma: two separate primaries or metastatic disease? A case solved with NRAS and CDKN2A (INK4A-ARF) mutational analysis.
|
Virchows Arch
|
2008
|
0.75
|
116
|
Molecular analysis as a tool in the differential diagnosis of VHL disease-related tumors.
|
Diagn Mol Pathol
|
2005
|
0.75
|